Novo CEO pressed by Senate to cut costs of obesity, diabetic issues medicines CEO Lars Fruergaard Jørgensen advised lawmakers the business would consider new talks with insurers about the list prices of Wegovy and copyright should they pledge to keep the medicines on their formularies. This strategy aligns with Individuals https://arizonahardteacarbs21751.blogolenta.com/27543776/the-5-second-trick-for-healthcare-news